New AI-based biomarker can help predict immunotherapy response for patients with lung cancer

In a retrospective study, a team of researchers from several health care systems and universities, including Emory University, has discovered a new artificial intelligence (AI)-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy. The findings, which were published in the journal Science Advances, not only offer guidance for patients and their physicians making treatment decisions, but can also curtail the financial burden associated with immunotherapy.

Related Keywords

United States , American , Anant Madabhushi , Vamsi Velcheti , Mehdi Alilou , Mohammadhadi Khorrami , University Hospitals In Cleveland , Langone Health , Emory University , Winship Cancer Institute Of Emory University , Langone Perlmutter Cancer Center , Georgia Institute Of Technology College Engineering , Engineering Center , Stony Brook University , Case Western Reserve University , American Cancer Society , Science Advances , Biomedical Engineering , Emory University School , Georgia Institute , Technology College , American Cancer , Cancer Immunology , Winship Cancer Institute , Cleveland Clinic , University Hospitals , Weill Cornell Medicine , Perlmutter Cancer Center ,